Kyle Fahrbach

16.4k total citations · 5 hit papers
85 papers, 12.2k citations indexed

About

Kyle Fahrbach is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Physiology. According to data from OpenAlex, Kyle Fahrbach has authored 85 papers receiving a total of 12.2k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Surgery, 13 papers in Pulmonary and Respiratory Medicine and 12 papers in Physiology. Recurrent topics in Kyle Fahrbach's work include Health Systems, Economic Evaluations, Quality of Life (6 papers), Chronic Lymphocytic Leukemia Research (5 papers) and Diet and metabolism studies (5 papers). Kyle Fahrbach is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (6 papers), Chronic Lymphocytic Leukemia Research (5 papers) and Diet and metabolism studies (5 papers). Kyle Fahrbach collaborates with scholars based in United States, United Kingdom and Germany. Kyle Fahrbach's co-authors include Hēnry Buchwald, Michael D. Jensen, Walter J. Pories, Karen M Schoelles, Yoav Avidor, Eugene Braunwald, Rhonda Estok, Isabella Sledge, John P. Bantle and Luba Nalysnyk and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Kyle Fahrbach

81 papers receiving 11.7k citations

Hit Papers

Bariatric Surgery 2004 2026 2011 2018 2004 2009 2007 2007 2007 1000 2.0k 3.0k 4.0k 5.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Bariatric Surgery
    2004 5.1k citations Kyle Fahrbach et al. profile →
  2. Weight and Type 2 Diabetes after Bariatric Surgery: Systematic Review and Meta-analysis
    2009 1.9k citations Rhonda Estok, Kyle Fahrbach et al. profile →
  3. Intermediate and Long-Term Outcomes of Total Ankle Arthroplasty and Ankle Arthrodesis
    2007 534 citations Rhonda Estok, Kyle Fahrbach et al. Journal of Bone and Joint Surgery profile →
  4. The Natural History and Prognosis of Neovascular Age-Related Macular Degeneration
    2007 490 citations Kyle Fahrbach et al. profile →
  5. Meta-Analysis of Alignment Outcomes in Computer-Assisted Total Knee Arthroplasty Surgery
    2007 429 citations Thomas K. Fehring, Rhonda Estok et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kyle Fahrbach United States 32 7.6k 3.8k 1.7k 1.4k 1.0k 85 12.2k
Martin Neovius Sweden 54 2.4k 0.3× 1.8k 0.5× 777 0.5× 619 0.4× 1.0k 1.0× 208 10.6k
Amanda Lee United Kingdom 67 5.4k 0.7× 2.7k 0.7× 142 0.1× 1.2k 0.8× 2.6k 2.5× 376 17.3k
Peter T. Donnan United Kingdom 60 2.5k 0.3× 1.4k 0.4× 167 0.1× 2.5k 1.8× 1.4k 1.3× 260 13.1k
Peter Jacobson United States 43 2.2k 0.3× 2.2k 0.6× 699 0.4× 977 0.7× 795 0.8× 205 6.7k
A Toby Prevost United Kingdom 55 1.2k 0.2× 1.3k 0.3× 599 0.4× 1.4k 1.0× 508 0.5× 236 9.3k
Jill L Colquitt United Kingdom 35 3.1k 0.4× 1.3k 0.3× 1.1k 0.7× 526 0.4× 502 0.5× 62 6.1k
Larry J. Prokop United States 67 3.6k 0.5× 1.3k 0.3× 296 0.2× 4.0k 2.8× 1.1k 1.1× 284 16.7k
Francine Kaufman United States 52 3.7k 0.5× 1.5k 0.4× 372 0.2× 7.0k 4.9× 686 0.7× 190 12.6k
Rolf Holle Germany 58 1.7k 0.2× 2.0k 0.5× 652 0.4× 2.4k 1.7× 1.2k 1.2× 293 13.0k
R. Curtis Ellison United States 61 2.1k 0.3× 1.9k 0.5× 252 0.2× 2.1k 1.5× 3.0k 2.9× 208 13.7k

Countries citing papers authored by Kyle Fahrbach

Since Specialization
Citations

This map shows the geographic impact of Kyle Fahrbach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kyle Fahrbach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kyle Fahrbach more than expected).

Fields of papers citing papers by Kyle Fahrbach

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kyle Fahrbach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kyle Fahrbach. The network helps show where Kyle Fahrbach may publish in the future.

Co-authorship network of co-authors of Kyle Fahrbach

This figure shows the co-authorship network connecting the top 25 collaborators of Kyle Fahrbach. A scholar is included among the top collaborators of Kyle Fahrbach based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kyle Fahrbach. Kyle Fahrbach is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Warren, Richard B., Kerry Donnelly, V. Taieb, et al.. (2024). Long-Term Efficacy and Safety of Bimekizumab and Other Biologics in Moderate to Severe Plaque Psoriasis: Updated Systematic Literature Review and Network Meta-analysis. Dermatology and Therapy. 14(11). 3133–3147. 1 indexed citations
2.
Liu, Xuejun, Daniela R. Junqueira, Kyle Fahrbach, et al.. (2024). Risk of Venous Thromboembolism by Cancer Type: A Network Meta-Analysis. Seminars in Thrombosis and Hemostasis. 50(3). 328–341. 8 indexed citations
3.
4.
Fahrbach, Kyle, Binod Neupane, Mahmoud Slim, et al.. (2023). Handling related publications reporting real-world evidence in network meta-analysis: a case study in multiple sclerosis. Journal of Comparative Effectiveness Research. 12(8). e220132–e220132. 1 indexed citations
5.
Schnitzler, Alfons, Andreas Freitag, Ike Iheanacho, et al.. (2022). AbobotulinumtoxinA Doses in Upper and Lower Limb Spasticity: A Systematic Literature Review. Toxins. 14(11). 734–734. 8 indexed citations
6.
Chanan‐Khan, Asher, et al.. (2022). Efficacy of first-line treatment for chronic lymphocytic leukemia: A Bayesian network meta-analysis.. Journal of Clinical Oncology. 40(16_suppl). e19526–e19526. 1 indexed citations
7.
Silverberg, Jonathan I., Jacob P. Thyssen, Kyle Fahrbach, et al.. (2021). Comparative efficacy and safety of systemic therapies used in moderate‐to‐severe atopic dermatitis: a systematic literature review and network meta‐analysis. Journal of the European Academy of Dermatology and Venereology. 35(9). 1797–1810. 86 indexed citations
8.
Gandhi, Pranav, et al.. (2021). Cost-effectiveness of empagliflozin versus canagliflozin, dapagliflozin, or standard of care in patients with type 2 diabetes and established cardiovascular disease. BMJ Open Diabetes Research & Care. 9(1). e001313–e001313. 19 indexed citations
9.
Curran, Desmond, Andrea Callegaro, Kyle Fahrbach, et al.. (2021). Meta-Regression of Herpes Zoster Incidence Worldwide. Infectious Diseases and Therapy. 11(1). 389–403. 45 indexed citations
10.
Jakes, Rupert W., Namhee Kwon, Beth Nordstrom, et al.. (2021). Burden of illness associated with eosinophilic granulomatosis with polyangiitis: a systematic literature review and meta-analysis. Clinical Rheumatology. 40(12). 4829–4836. 36 indexed citations
11.
12.
Weisel, Katja, Pieter Sonneveld, Andrew Spencer, et al.. (2018). A comparison of the efficacy of immunomodulatory-free regimens in relapsed or refractory multiple myeloma: a network meta-analysis. Leukemia & lymphoma. 60(1). 151–162. 7 indexed citations
13.
Dimopoulos, Meletios Α., Jonathan L. Kaufman, Darrell White, et al.. (2018). A Comparison of the Efficacy of Immunomodulatory-containing Regimens in Relapsed/Refractory Multiple Myeloma: A Network Meta-analysis. Clinical Lymphoma Myeloma & Leukemia. 18(3). 163–173.e6. 18 indexed citations
14.
Kaufman, Howard L., Lawrence H. Schwartz, William N. William, et al.. (2018). Evaluation of classical clinical endpoints as surrogates for overall survival in patients treated with immune checkpoint blockers: a systematic review and meta-analysis. Journal of Cancer Research and Clinical Oncology. 144(11). 2245–2261. 23 indexed citations
15.
Stelljes, Matthias, Yun Su, Kyle Fahrbach, et al.. (2017). Indirect Treatment Comparison (ITC) of Inotuzumab Ozogamicin (InO) and Blinatumomab (Blina) for Relapsed or Refractory (RR) Acute Lymphoblastic Leukemia (ALL). Blood. 130. 2558–2558. 1 indexed citations
16.
Rao, Stephen M., et al.. (2014). Correlations between MRI and Information Processing Speed in MS: A Meta-Analysis. SHILAP Revista de lepidopterología. 2014. 1–9. 68 indexed citations
17.
Fahrbach, Kyle, Amber Martin, Edward Kim, et al.. (2013). Relating relapse and T2 lesion changes to disability progression in multiple sclerosis: a systematic literature review and regression analysis. BMC Neurology. 13(1). 180–180. 25 indexed citations
18.
Mason, James, Thomas K. Fehring, & Kyle Fahrbach. (2007). Navigated Total Knee Replacement. Journal of Bone and Joint Surgery. 89(11). 2547–2548. 1 indexed citations
19.
Fahrbach, Kyle, et al.. (2003). Diagnosis and treatment of Parkinson's disease: a systematic review of the literature.. PubMed. 1–4. 33 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Martin Neovius Breakdown of academic impact, for papers by Amanda Lee Breakdown of academic impact, for papers by Peter T. Donnan Breakdown of academic impact, for papers by Peter Jacobson Breakdown of academic impact, for papers by A Toby Prevost Breakdown of academic impact, for papers by Jill L Colquitt Breakdown of academic impact, for papers by Larry J. Prokop Breakdown of academic impact, for papers by Francine Kaufman Breakdown of academic impact, for papers by Rolf Holle Breakdown of academic impact, for papers by R. Curtis Ellison
Rankless by CCL
2026